




　Introduction: This study aimed to examine the efficacy of intra-institutional standardization of fluoroscopy 
use to reduce X-ray exposure and identify factors that predict reduced fluoroscopy time.
　Methods: We recruited 231 patients who underwent ureteroscopy at our institution between April 2017 and 
March 2019. The patients were divided into two groups‚ group A （ureteroscopy after standardization） and group 
B （ureteroscopy before standardization）. The clinical factors that reduced fluoroscopy time were identified 
using a multivariate regression model.
　Results: Fluoroscopy time was significantly shorter in group A （0.22 min） than in group B （1.11 min; p = 
0.012）; however‚ no significant difference in surgical outcomes including stone free status and postoperative 
complications was found between the groups. The multivariate regression model identified ureteroscopy with 
standardizing the fluoroscopic use （odds ratio: 23.90‚ 10.59-50.98; p < 0.001） and ureteroscopy without 
postoperative ureter stent placement （odds ratio: 4.38‚ 1.98-9.68; p < 0.001） as independent contributors to 
reduced fluoroscopy time.
　Conclusion: The proposed standardization succeeded to minimized fluoroscopy time without compromising 
surgical outcomes.
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INTRODUCTION
　Ureteroscopy （URS） has been performed as a treatment for 
urinary stones for more than 30 years‚ and various clinical 
practice guidelines have recently recommended it as a 
standard therapy for upper urinary stones.1-3） Complications 
are generally minor‚ and serious complications‚ such as 
postoperative sepsis and ureteral rupture‚ have been reported 
in only 2.39% of cases.4） Cases of solitary kidney5） or bilateral 
intervention performed in a single session6） have been reported 
owing to fewer complications. URS is typically performed 
under fluoroscopy to facilitate the safe use of a rigid or 
flexible ureteroscope‚ ureteral access sheath （UAS）‚ and guide 
wire （GW）. Exposure to fluoroscopy causes various adverse 
changes to the human body‚ such as cataract‚7） infertility8‚ 9） and 
some malignant neoplasms.10） Therefore‚ surgeons should 
reduce the X-ray exposure during surgery‚ not only for the 
patients but also for medical staff including themselves. Based 
on the recommendations of the International Commission on 
Radiological Protection （ICRP）‚ the maximum effective dose 
for medical workers is 100 mSv for five years and 50 mSv for 
one year; the annual exposure threshold for the public is 
within 1 mSv. Although the effective dose due to medical 
exposure is not limited‚ X-ray exposure to patients undergoing 
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URS has been reported to be 1.13 mSv at a fluoroscopy 
duration of 47s‚11） which exceeds the public dose limit. The 
intraoperative exposure dose to surgeons and assistants in 
URS is 11.6 µGy for the lower limbs and 1.9 µGy for the eyes‚ 
with a fluoroscopy duration of 78 s.12） The ICRP advocates the 
principle of radiation protection （as low as possible）‚ and 
urologists should try to reduce X-ray exposure during URS by 
reducing fluoroscopy time and using appropriate protection.13）
　Many reports have addressed the factors that contribute to the 
extension of fluoroscopy time12‚ 14） and investigated measures to 
reduce X-ray use and their efficacy . At our hospital ‚ 
intraoperative fluoroscopy was previously used at the discretion 
of each operator until May 2018 when we started to standardize 
fluoroscopy usage to minimize fluoroscopy time during URS. 
Since cases have accumulated after intra-institutional 
standardization‚ we investigated the efficacy of standardization 
on fluoroscopy time and surgical outcome of URS by 
performing a retrospective single institution comparative study.
MATERIALS AND METHODS
　We analyzed 231 patients with URS who were treated at our 
hospital between April 2017 and March 2019. In all‚ 36 URS 
cases involving simultaneous bilateral URS or other 
simultaneous operations were excluded. The clinical criteria 
for  the select ion of  shockwave l i thotr ipsy （SWL）‚ 
percutaneous nephrolithotomy （PCNL）‚ and URS for the 
treatment of urinary stones at our institution were as follows. 
For urinary stones > 20 mm in diameter‚ PCNL is offered as 
the first-line treatment‚ with URS offered as the second choice.
　The final selection of the treatment modality is based on the 
patient's preference.
　Intra-institutional standardization for fluoroscopic use was 
initiated after May 2018. The patients were divided into two 
groups: group A‚ URS after standardization‚ which was 
performed after May 2018 （n = 118）; group B‚ URS before 
standardization‚ which was performed before April 2018 as a 
historical control （n = 113）. The following patient data for 
both groups were collected from medical records: age‚ sex‚ 
height‚ weight‚ body mass index （BMI）‚ affected side‚ number 
of stones‚ position of stone‚ stone at low calyx‚ number of 
stones at the calyx‚ stone volume‚ cumulative stone distance 
（CSD）‚ maximum value of computer tomography （CT）‚ 
average value of CT‚ preoperative hydronephrosis‚ pre-stent‚ 
history of SWL‚ surgeon experience‚ and assistant experience 
and surgical results including stone free status‚ postoperative 
complications‚ and fluoroscopic time.
　The 231 URS cases were further divided into two groups as 
follows based on the median fluoroscopy time （33.9 s）: low-
dose group （ < 33.9 s‚ n = 116） and high-dose group （ > 33.9 
s‚ n = 115）. Factors contributing to reduce the fluoroscopy 
time were identified using logistic regression analysis.
　Statistical calculations were performed using SPSS version 
19 （IBM Corporation‚ Armonk‚ NY‚ USA）.
Surgical technique
　The patients were intravenously administered a preoperative 
antibiotic and then placed in the lithotomy position under 
anesthesia. At our institution‚ either the surgeon or assistant has 
URS experience more than 50 cases to ensure safety . 
Subsequently‚ the urethra and urinary bladder were observed 
using a 22.5 Fr cystoscope. An 8.6 Fr rigid ureteroscope 
（Olympus‚ Tokyo‚ Japan） was inserted under the GW until it 
reached the stone or renal pelvis. A hydrophilic UAS （10/12 Fr 
Bi-Flex‚ Edap Technomed） was inserted with the GW under 
fluoroscopic guidance. A flexible ureteroscope （4.9/7.95 Fr 
URF-P6‚ Olympus‚ Tokyo‚ Japan） was utilized to crush stones 
using a holmium yttrium aluminum garnet laser （Ho-YAG 200 
µm‚ Luminous‚ or 270 µm‚ Dornier） and to extract fragments 
with a stone basket （1.5 Fr Dormia No-Tip‚ Coloplast） until 
absence of fragments except minute dust‚ could be confirmed 
with both endoscopy and fluoroscopy. Postoperative stents 
were inserted for patients with a surgical duration > 60 min‚ > 
70 years‚ female sex‚ solitary kidney cases‚ and other cases for 
whom the surgeon judged to require stents. In other cases‚ a 6 
Fr overnight urethral catheter was placed in the ureter. Stone-
free status was defined as the absence of visible fragments in 
the kidney-ureter-bladder film （KUB） two weeks after 
removal of ureteral stents or overnight catheter.
Standardization of using intraoperative fluoroscopy
　It was recommended that surgeons used fluoroscopic 
guidance at five situations‚ namely to confirm the position of 
the rigid ureteroscopy at the level of the stone or renal pelvis‚ 
immediately before insertion of the UAS‚ during adjustment of 
the tip of the UAS‚ during residual stone evaluation‚ and 
during postoperative ureteral stent placement.
　The C-arm position was set preoperatively by the surgeon 
without fluoroscopic guidance‚ considering the position of the 
pelvic urinary tract or target calculus. Intermittent output was 
recommended when fluoroscopy was necessary.
RESULTS
　Stone volume （0.26 mL vs. 0.48 mL; p = 0.001） and CSD 
（11.1 mm vs. 14.7 mm; p < 0.001） were smaller in group A 
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than in group B （Table 1）. There were fewer patients with 
h y d r o n e p h r o s i s  （38.1%  v s .  63.7% ;  p  <  0.001） a n d 
preoperative stent placement （47.4% vs. 61.6%; p = 0.031） in 
group A than in group B. Surgeon experience was lower in 
group A （less than 50 URS experience: 54.2% vs. 38.1%; p = 
0.014）. UAS was used frequently in both groups.
　Surgical （70 min vs. 78 min; p = 0.012） and fluoroscopy 
（0.22 min vs. 1.11 min; p = 0.012） times and fluoroscopy dose 
（0.97 mGy vs. 3.51 mGy; p < 0.001） were lower in group A 
than group B （Table 2）. However‚ no significant differences 
Group A Group B
P value
median / No. range （%） median / No. range （%）
Age 62 20－94 60 22－85  0.555 
sex female 34 （28.8） 36 （31.9）  0.615 
height ［cm］ 165 140－183.5 165 140－178  0.434 
weight ［kg］ 65.7 33.7－114.5 64.0 35.9－97.2  0.212 
BMI 24.1 14.2－39.8 23.5 15.5－33.6  0.333 
Affected side right 50 （42.4） 48 （42.5）  0.987 
Number of stone 1 1－10 1 1－16  0.185 
Stone at low calyx 39 （33.3） 40 （35.4）  0.742 
Number of stone at calyx 0 0－3 0 0－7  0.081 
Stone volume ［ml］ 0.26 0.04－2.11 0.48 0.03－3.18  0.001 *
CSD ［mm］ 11.1 0.78－118 14.7 1.06－73.4  < 0.001 *
Maximum value of CT ［HU］ 1292 435－1940 1137 233－1882  0.029 *
Average value of CT ［HU］ 801 277－1476 824 226－1732  0.721 
Preoperative hydronephrosis 45 （38.1） 72 （63.7）  < 0.001 *
Pre-stent 55 （47.4） 69 （61.6）  0.031 *
History of SWL 9 （7.6） 5 （3.5）  0.178 
Using UAS 89 （75.4） 94 （83.2）  0.146 
Surgeon experience < 50 cases 64 （54.2） 43 （38.1）  0.014 *
Assistant experience < 50 cases 23 （19.5） 16 （14.2）  0.279 
CSD : cumulative stone distance
UAS : ureteral access sheath
SWL : shock wave lithotripsy
* significant difference
Table 1. patient background
Table 2. surgical results
Group A Group B
P value
median / No. range （%） median / No. range （%）
f－URS 94 （79.7） 100 （88.5）  0．067 
Operation time ［min］ 70 17－144 78 26－143  0．012 *
postoperative stent placement 53 （55.1） 69 （61.1）  0．358 
Stone free 101 （85.6） 96 （85.0）  0．891 
Fluoroscopy time ［min］ 0.22 0－2.4 1.11 0.2－11.14  0．012 *
fluoroscopy ［mGy］ 0.97 0－18.4 3.51 0.66－99.9  < 0．001 *
Postoperative fever （ > 38℃） 10 （8.5） 12 （10.6）  0．579 
Using catecholamine 0 （0） 1 （0.9）  0．306 
Injury of ureter or renal pelvis 4 （3.4） 4 （3.5）  0．950 
Length of postoperative stay 2 2－12 2 2－11  0．891 
Stone analysis
Calcium oxalate 85 （72.6） 63 （55.8）
 0．008 *
Calcium phosphate 2 （1.7） 10 （8.8）
Uric acid 2 （1.7） 6 （5.3）
Struvite 1 （0.9） 3 （2.7）
Mix 24 （20.5） 22 （19.5）
Others 2 （1.7） 1 （0.9）
unknown 1 （0.9） 8 （7.1）
* significant difference
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were observed between the two groups in terms of stone-free 
rate‚ complications （postoperative fever‚ use of catecholamines 
and injury of ureter or renal pelvis）‚ or cases in which flexible 
URS （f-URS） was used. In group B‚ one patient had a ureteral 
perforation during UAS insertion; however‚ no serious 
complications occurred in group A. Other complications were 
minor‚ such as ureteral mucosal contusions.
　Multivariate analysis revealed that URS after standardization 
（odds ratio ‚ 22.03; p < 0.001） and postoperative stent 
placement （odds ratio‚ 3.91; p < 0.001） were independent 
predictors of reduced fluoroscopy time （Table 3）. In contrast‚ 
CSD‚ stone volume‚ preoperative hydronephrosis‚ and UAS use 
were not significant contributing factors to fluoroscopy time.
　UAS use significantly increased fluoroscopy time in group 
B （p = 0.045） compared to group A （Table 4）.
DISCUSSION
　The standardization described in the present report aimed to 
minimize fluoroscopic time during URS. This standardization 
resulted in a notable decrease in fluoroscopic time‚ which 
indicates that excessive and unnecessary fluoroscopy was used 
during the URS.
　In Japan‚ in the manual on upper urinary tract stone 
endoscopy‚15） use of X-ray fluoroscopy is recommended 
during UAS insertion. Although the fluoroscopy duration 
associated with URS insertion can be significantly reduced 
（Table 4）‚ the results of the multivariate analysis （Table 3） 
indicated that the use of UAS was not a significant factor 
associated with fluoroscopic time. Based on previous reports‚ the 
average fluoroscopy time for URS was 0.73- 2.74 min12‚ 14‚ 16-18）. 
Our fluoroscopic time was relatively short before standardization 
（1.11 min）. We speculate that this is the reason that the UAS was 
not a significant factor associated with fluoroscopic time in the 
multivariate analysis.
　Multivariate analysis revealed that stone volume and CSD 
were not independent factors associated with prolonged 
fluoroscopy time‚ since fluoroscopy was not used in the 
stone crushing and extraction processes even prior to 
standardization.
　Postoperative stent placement was a significant factor 
prolonging fluoroscopy time. Khoury et al.19） reported that 
URS ‚ including postoperative stent placement ‚ can be 
performed safely without fluoroscopy in children ‚ and 
Aboutaleb et al.20） reported the same results for adult URS 
procedures. However‚ in 9-18% of cases‚ operators were 
unable to insert a stent‚ and complications of stent intrusion or 
dropout have been reported. In order to reduce bladder 
irritation symptoms‚ direct measurement of ureter length using 
a ureteral catheter was adopted in our hospital; therefore‚ 
postoperative stent placement prolonged the fluoroscopic time 
at our hospital.
　Tepeler et al.21） reported that postoperative stent placement 
was not necessary in case of URS with lower ureteral stones‚ 
accounting for more than one-half of cases‚ and surgery 
duration within 60 min‚ except in patients with anatomical 
abnormalities and ureteral strictures. The average fluoroscopy 
time was reported to be 0.15 min. In our study‚ approximately 
80% of patients had kidney stones and upper ureteral stones‚ 
75% used UAS‚ and > 50% underwent postoperative ureteral 
stent placement‚ with a median fluoroscopy time of 0.22 min.
　Ngo et al.14） reported that the average fluoroscopy time 
could be reduced by 24% by consciously reducing the use of 
intraoperative fluoroscopy by the surgeon. Greene et al.16） 
Table 3. multivariate analysis of factors contributing to fluoroscopy time extension
Full model Reduced model
P value Odds 95% CI P value Odds 95% CI
CSD 0.584 0.79 0.33－1.87
Stone volume 0.905 1.06 0.43－2.58
Preoperative hydronephrosis 0.957 1.07 0.52－2.18
Without reduction technique < 0.001 23.90 10.59－50.98 < 0.001* 22.03 10.67－45.49
UAS 0.439 0.70 0.28－1.73
Postoperative stent placement < 0.001 4.38 1.98－9.68 < 0.001* 3.91 1.88－8.16
* significant difference
Table 4.  influence on fluoroscopy time by using ureteral 
access sheath
Fluoroscopy 
time ［min］ Range P value
Group A
Without UAS 0.10 0－2.4
0.067
With UAS 0.25 0.035－1.9
Group B
Without UAS 0.76 0.2－3.0
0.045*
With UAS 1.16 0.28－11.14
* significant difference
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could reduce intraoperative fluoroscopy time by 82% by 
limiting fluoroscopy in 60 simple cases without additional 
procedures such as balloon dilatation‚ without compromising 
surgical outcome. In this study‚ we examined 231 cases 
including high-difficulty cases such as multiple stones and 
lower renal calyx stones ‚ and achieved a reduction in 
fluoroscopy time of about 80% without compromising surgical 
outcomes.
　The URS procedure is equivalent to 1.13 mSv at a 
fluoroscopy time of 47s.11） According to Meltter et al.‚22） the 
effective dose is equivalent to approximately one abdominal 
KUB radiograph . After standardization ‚ URS could be 
performed with approximately one-quarter of the dose 
required for a KUB radiograph. Reduced fluoroscopy time 
may provide more benefits not only to patients‚ but also to 
medical staff‚ surgeons‚ assistants‚ and anesthesia personnel 
who participate in or perform many URSs in their lifetimes. In 
high-volume centers‚ the cumulative difference is likely to be 
large. There is no doubt reducing fluoroscopic time; however‚ 
fluoroscopy time should be reduced only when possible 
without  affect ing surgical  safety .  Therefore ‚  more 
sophisticated standardization is warranted to maintain the 
balance between surgical safety and fluoroscopy time.
　As the present investigation was a single-institution study‚ 
institutional bias was difficult to eliminate. Minor differences 
between institutions with respect to surgical techniques may be 
associated with different outcomes and require different 
standardization.
　In our study‚ although patient backgrounds （stone volume‚ 
and CSD‚ among others） significantly differed between groups 
A and B‚ the multivariate analysis revealed that these factors 
did not have a significant impact independently. As this was a 
retrospective analysis‚ the influence of a conscientious 
reduction in fluoroscopy time by the operators and assistants 
cannot be eliminated. However‚ we assume that this may be 
due to the essential effect of standardization‚ since awareness 
of fluoroscopy use under intra-institutional standardization 
resulted in a remarkable reduction in fluoroscopy time. In 
conclusion‚ we successfully reduced fluoroscopy time during 
URS by introducing an intra-institutional standardization for 
fluoroscopic use. Urologists should pay attention to the 
amount of X-ray exposure‚ for patients and medical staff while 
ensuring a safe procedure.
　This study was conducted with the approval of the ethics 
committee at our hospital‚ and patient data was collected only 
after obtaining written consent.
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